Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antagonist activity at VDR LBD (unknown origin) using Alexa Fluor 647-labeled SRC2-3 as substrate incubated for 2 hrs in presence of calcitriol by fluorescence polarization assay
Assay data:1 Active, 3 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Anti-tumor activity against tumor cells in TH-MYCN +/+ neuroblastoma 129x1/SvJ.Tg (TH-MYCN)41Waw/Nci mouse model assessed as reduction in tumor weight at 10 mg/kg, ip measured on day 7 by ultrasound imaging analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Anti-tumor activity against TH-MYCN +/+ transgenic neuroblastoma 129x1/SvJ.Tg (TH-MYCN)41Waw/Nci mouse model assessed as reduction in tumor growth at 10 mg/kg, ip measured upto 7 days by ultrasound imaging analysis
Cytotoxicity against tumor cells in TH-MYCN +/+ transgenic neuroblastoma 129x1/SvJ.Tg (TH-MYCN)41Waw/Nci mouse model assessed as reduction in cell viability at 0.1 to 10 uM measured after 3 days by MTS assay
Anti-tumor activity against human BE2C cells xenografted in NSG mouse assessed as reduction in tumor volume at 10 mg/kg, ip measured for 5 to 8 days
Anti-tumor activity against human SH-SY5Y cells xenografted in NSG mouse assessed as reduction in tumor volume at 10 mg/kg, ip measured for 5 to 10 days
Anti-tumor activity against human BXPC-3 cells xenografted in NSG mouse assessed as reduction in tumor growth at 10 mg/kg, ip measured on day 18
Anti-tumor activity against human PANC-1 cells xenografted in NSG mouse assessed as reduction in tumor growth at 10 mg/kg, ip measured on day 12
Anti-tumor activity against human D283 Med cells xenografted in NSG mouse assessed as reduction in tumor size at 10 mg/kg, ip measured on day 12
Anti-tumor activity against human D283 Med cells xenografted in NSG mouse assessed as reduction in tumor volume at 10 mg/kg, ip measured on day 12
Downregulation of VDR expression in tumor of NSG mouse xenografted with human SK-OV-3 cells at 10 mg/kg, ip by confocal microscopy based immunohistochemistry analysis
Anti-tumor activity against human SK-OV-3 cells xenografted in NSG mouse assessed as reduction in tumor growth at 10 mg/kg, ip measured for 1 to 39 days
Anti-tumor activity against human ES2 cells xenografted in NSG mouse assessed as reduction in tumor volume at 10 mg/kg, ip measured upto 30 days
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on